92 related articles for article (PubMed ID: 14533937)
1. Cdc2 expression in primary thyroid lymphoma: its relationship with biological aggressiveness and G2 cyclins.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Pathol Res Pract; 2003; 199(8):533-8. PubMed ID: 14533937
[TBL] [Abstract][Full Text] [Related]
2. Expression of G2-M modulators in thyroid neoplasms: correlation of cyclin A, B1 and cdc2 with differentiation.
Ito Y; Yoshida H; Nakano K; Takamura Y; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Pathol Res Pract; 2002; 198(6):397-402. PubMed ID: 12166896
[TBL] [Abstract][Full Text] [Related]
3. p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells.
Winters ZE; Ongkeko WM; Harris AL; Norbury CJ
Oncogene; 1998 Aug; 17(6):673-84. PubMed ID: 9715268
[TBL] [Abstract][Full Text] [Related]
4. Geldanamycin induces G2 arrest in U87MG glioblastoma cells through downregulation of Cdc2 and cyclin B1.
Nomura N; Nomura M; Newcomb EW; Zagzag D
Biochem Pharmacol; 2007 May; 73(10):1528-36. PubMed ID: 17324379
[TBL] [Abstract][Full Text] [Related]
5. Expression of the components of the Cip/Kip family in malignant lymphoma of the thyroid.
Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
Pathobiology; 2004; 71(3):164-70. PubMed ID: 15051930
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest.
Park M; Chae HD; Yun J; Jung M; Kim YS; Kim SH; Han MH; Shin DY
Cancer Res; 2000 Feb; 60(3):542-5. PubMed ID: 10676633
[TBL] [Abstract][Full Text] [Related]
7. Expression of the G2-M modulators in pancreatic adenocarcinoma.
Ito Y; Takeda T; Wakasa K; Tsujimoto M; Okada M; Matsuura N
Pancreatology; 2002; 2(2):138-45. PubMed ID: 12123094
[TBL] [Abstract][Full Text] [Related]
8. Expression of the G2-M checkpoint regulators cyclin B1 and cdc2 in nonmalignant and malignant human breast lesions: immunocytochemical and quantitative image analyses.
Kawamoto H; Koizumi H; Uchikoshi T
Am J Pathol; 1997 Jan; 150(1):15-23. PubMed ID: 9006317
[TBL] [Abstract][Full Text] [Related]
9. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells.
Poon RY; Chau MS; Yamashita K; Hunter T
Cancer Res; 1997 Nov; 57(22):5168-78. PubMed ID: 9371520
[TBL] [Abstract][Full Text] [Related]
10. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line.
Badie C; Bourhis J; Sobczak-Thépot J; Haddada H; Chiron M; Janicot M; Janot F; Tursz T; Vassal G
Br J Cancer; 2000 Feb; 82(3):642-50. PubMed ID: 10682678
[TBL] [Abstract][Full Text] [Related]
11. TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression.
Ryu MS; Lee MS; Hong JW; Hahn TR; Moon E; Lim IK
Exp Cell Res; 2004 Sep; 299(1):159-70. PubMed ID: 15302583
[TBL] [Abstract][Full Text] [Related]
12. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
Minemoto Y; Gannon J; Masutani M; Nakagama H; Sasagawa T; Inoue M; Masamune Y; Yamashita K
Exp Cell Res; 2001 Jan; 262(1):37-48. PubMed ID: 11120603
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of cyclin B1 and cdc2 expression during 9-nitrocamptothecin-induced regression of DU145 prostate tumor.
Chatterjee D; Wyche JH; Pantazis P
Anticancer Res; 2000; 20(6B):4477-82. PubMed ID: 11205291
[TBL] [Abstract][Full Text] [Related]
14. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.
Zhan Q; Antinore MJ; Wang XW; Carrier F; Smith ML; Harris CC; Fornace AJ
Oncogene; 1999 May; 18(18):2892-900. PubMed ID: 10362260
[TBL] [Abstract][Full Text] [Related]
15. TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid leukemia cells.
Hu X; Cui D; Moscinski LC; Zhang X; Maccachero V; Zuckerman KS
Cytokine; 2007 Feb; 37(2):155-62. PubMed ID: 17459720
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Oncology; 2000 Jun; 59(1):68-74. PubMed ID: 10895070
[TBL] [Abstract][Full Text] [Related]
17. Effect of dexamethasone on the expression of p34(cdc2) and cyclin B1 in pig oocytes in vitro.
Chen WY; Yang JG; Li PS
Mol Reprod Dev; 2000 May; 56(1):74-9. PubMed ID: 10737969
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
[TBL] [Abstract][Full Text] [Related]
19. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.
Seol JG; Park WH; Kim ES; Jung CW; Hyun JM; Kim BK; Lee YY
Biochem Biophys Res Commun; 1999 Nov; 265(2):400-4. PubMed ID: 10558879
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
